dc.contributor.author | Cashman, Kevin D. | |
dc.contributor.author | Dowling, Kirsten G. | |
dc.contributor.author | Škrabáková, Zuzana | |
dc.contributor.author | Gonzalez-Gross, Marcela | |
dc.contributor.author | Valtueña, Jara | |
dc.contributor.author | De Henauw, Stefaan | |
dc.contributor.author | Moreno, Luis | |
dc.contributor.author | Damsgaard, Camilla T. | |
dc.contributor.author | Michaelsen, Kim F. | |
dc.contributor.author | Mølgaard, Christian | |
dc.contributor.author | Jorde, Rolf | |
dc.contributor.author | Grimnes, Guri | |
dc.contributor.author | Moschonis, George | |
dc.contributor.author | Mavrogianni, Christina | |
dc.contributor.author | Manios, Yannis | |
dc.contributor.author | Thamm, Michael | |
dc.contributor.author | Mensink, Gert B.M. | |
dc.contributor.author | Rabenberg, Martina | |
dc.contributor.author | Busch, Markus A. | |
dc.contributor.author | Cox, Lorna | |
dc.contributor.author | Meadows, Sarah | |
dc.contributor.author | Goldberg, Gail | |
dc.contributor.author | Prentice, Ann | |
dc.contributor.author | Dekker, Jacqueline M. | |
dc.contributor.author | Nijpels, Giel | |
dc.contributor.author | Pilz, Stefan | |
dc.contributor.author | Swart, Karin M. | |
dc.contributor.author | Van Schoor, Natasja M. | |
dc.contributor.author | Lips, Paul | |
dc.contributor.author | Eiriksdóttir, Gudny | |
dc.contributor.author | Gudnason, Vilmundur | |
dc.contributor.author | Cotch, Mary Frances | |
dc.contributor.author | Koskinen, Seppo | |
dc.contributor.author | Lamberg-Allardt, Christel | |
dc.contributor.author | Durazo-Arvizu, Ramon A. | |
dc.contributor.author | Sempos, Christopher T. | |
dc.contributor.author | Kiely, Mairead | |
dc.date.accessioned | 2017-03-06T10:05:36Z | |
dc.date.available | 2017-03-06T10:05:36Z | |
dc.date.issued | 2016-02-10 | |
dc.description.abstract | Background:<br>Vitamin D deficiency has been described as being pandemic, but serum 25-hydroxyvitamin D [25(OH)D] distribution data for the European Union are of very variable quality. The NIH-led international Vitamin D Standardization Program (VDSP) has developed protocols for standardizing existing 25(OH)D values from national health/nutrition surveys.<br>Objective:<br>This study applied VDSP protocols to serum 25(OH)D data from representative childhood/teenage and adult/older adult European populations, representing a sizable geographical footprint, to better quantify the prevalence of vitamin D deficiency in Europe.<br>Design:<br>The VDSP protocols were applied in 14 population studies [reanalysis of subsets of serum 25(OH)D in 11 studies and complete analysis of all samples from 3 studies that had not previously measured it] by using certified liquid chromatography–tandem mass spectrometry on biobanked sera. These data were combined with standardized serum 25(OH)D data from 4 previously standardized studies (for a total n = 55,844). Prevalence estimates of vitamin D deficiency [using various serum 25(OH)D thresholds] were generated on the basis of standardized 25(OH)D data.<br>Results:<br>An overall pooled estimate, irrespective of age group, ethnic mix, and latitude of study populations, showed that 13.0% of the 55,844 European individuals had serum 25(OH)D concentrations <30 nmol/L on average in the year, with 17.7% and 8.3% in those sampled during the extended winter (October–March) and summer (April–November) periods, respectively. According to an alternate suggested definition of vitamin D deficiency (<50 nmol/L), the prevalence was 40.4%. Dark-skinned ethnic subgroups had much higher (3- to 71-fold) prevalence of serum 25(OH)D <30 nmol/L than did white populations.<br>Conclusions:<br>Vitamin D deficiency is evident throughout the European population at prevalence rates that are concerning and that require action from a public health perspective. What direction these strategies take will depend on European policy but should aim to ensure vitamin D intakes that are protective against vitamin D deficiency in the majority of the European population. | en_US |
dc.description | Source: <a href=http://dx.doi.org//10.3945/ajcn.115.120873>doi: 10.3945/ajcn.115.120873</a> | en_US |
dc.identifier.citation | Cashman, K.D. et al. Vitamin D deficiency in Europe: pandemic?. American Journal of Clinical Nutrition. 2016;103(4):1033-1044 | en_US |
dc.identifier.cristinID | FRIDAID 1420158 | |
dc.identifier.doi | 10.3945/ajcn.115.120873 | |
dc.identifier.issn | 0002-9165 | |
dc.identifier.issn | 1938-3207 | |
dc.identifier.uri | https://hdl.handle.net/10037/10432 | |
dc.language.iso | eng | en_US |
dc.publisher | American Society for Nutrition | en_US |
dc.relation.journal | American Journal of Clinical Nutrition | |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750 | en_US |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750 | en_US |
dc.title | Vitamin D deficiency in Europe: pandemic? | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |